A Safety and Efficacy Study of OnabotulinumtoxinA in Premature Ejaculation

Clinical trial NCT01917006 · TERMINATED

Trial details

NCT number: NCT01917006
Sponsor: Allergan
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Premature Ejaculation

Start date: 2013-08-07
Primary completion: 2017-08-15
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.